Pathology and Laboratory Medicine
Episodes 17-32 of 32
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
- MinuteCE®
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
- MinuteCE®
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Regimens
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
- MinuteCE®
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
1.00 program creditCharu Aggarwal, MD, MPH
Alexander Drilon, MD
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
- Previous
- Next